rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Anna Mowry

CFO and Treasurer

Company insider

Files Form 4 as: CFO and Treasurer, Nautilus Biotechnology.

In numbers

Trades disclosed
11
Buys
5
Sells
0
Bought
$271K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
12 Aug 2021
Last trade
2 Mar 2026
Last filed
4 Mar 2026

Companies traded

Where they are an officer
NAUT Nautilus BiotechnologyOfficer · Life-science tools · last 2 Mar 20265 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
2 Mar 2026filed 4 Mar 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
2 Mar 2026filed 4 Mar 2026NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
29 May 2025filed 2 Jun 2025NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$12K15,000 at $0.77filing
3 Mar 2025filed 4 Mar 2025NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
1 Mar 2024filed 5 Mar 2024NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
27 Feb 2023filed 1 Mar 2023NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—160,000 at $0.00filing
19 Aug 2022filed 22 Aug 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$40K17,500 at $2.30filing
27 Jun 2022filed 28 Jun 2022NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$15K5,500 at $2.75filing
25 Feb 2022filed 25 Feb 2022NAUT Nautilus Biotechnologyoption or derivative · Life-science toolsSEC FORM 4 Code A—280,000 at $0.00filing
24 Nov 2021filed 24 Nov 2021NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$69K15,000 at $4.58filing
12 Aug 2021filed 16 Aug 2021NAUT Nautilus BiotechnologyLife-science toolsSEC FORM 4 Bought$135K17,500 at $7.71filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care5

Buys in green, sells in red, by the company’s sector.

Related people

Epperly Melissa BDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Farzad NazemDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Karen AkinsanyaOfficer · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Matthew S. McIlwainDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year
Matthew L. PosardDirector · Director at Nautilus Biotechnology, filing Form 4 there in the last year